The Transcription Factor GATA3 Is Critical for the Development of All IL-7Rα-Expressing Innate Lymphoid Cells  by Yagi, Ryoji et al.
Immunity
ArticleThe Transcription Factor GATA3 Is Critical
for the Development of All IL-7Ra-Expressing
Innate Lymphoid Cells
Ryoji Yagi,1,5,6 Chao Zhong,1,5 Daniel L. Northrup,2,5 Fang Yu,1 Nicolas Bouladoux,3 Sean Spencer,3 Gangqing Hu,2
Luke Barron,3 Suveena Sharma,1 Toshinori Nakayama,4 Yasmine Belkaid,3 Keji Zhao,2 and Jinfang Zhu1,*
1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases
2Systems Biology Center, National Heart, Lung, and Blood Institute
3Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases
National Institutes of Health, Bethesda, MD 20892, USA
4Department of Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
5These authors contributed equally to this work
6Present address: Department of Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
*Correspondence: jfzhu@niaid.nih.gov
http://dx.doi.org/10.1016/j.immuni.2014.01.012SUMMARY
Innate lymphoid cells (ILCs) are critical in innate im-
mune responses to pathogens and lymphoid organ
development. Similar to CD4+ T helper (Th) cell sub-
sets, ILC subsets positive for interleukin-7 receptor
a (IL-7Ra) produce distinct sets of effector cytokines.
However, the molecular control of IL-7Ra+ ILC devel-
opment and maintenance is unclear. Here, we report
that GATA3 was indispensable for the development
of all IL-7Ra+ ILC subsets and T cells but was not
required for the development of classical natural
killer cells. Conditionally Gata3-deficient mice had
no lymph nodes and were susceptible to Citrobactor
rodentium infection. After the ILCs had fully devel-
oped, GATA3 remained important for the mainte-
nance and functions of ILC2s. Genome-wide gene
expression analyses indicated that GATA3 regulated
a similar set of cytokines and receptors in Th2 cells
and ILC2s, but not in ILC3s. Thus, GATA3 plays
parallel roles in regulating the development and
functions of CD4+ T cells and IL-7Ra+ ILCs.
INTRODUCTION
CD4+ T helper (Th) cells are central in orchestrating adaptive
immune responses; distinct Th cell subsets are involved in pro-
tective immune responses to a variety of pathogens (Kanno
et al., 2012; Zhu et al., 2010). For example, type 1 T helper
(Th1) cells are critical for eradicating intracellular bacteria and
viruses, whereas type 2 Th (Th2) cells are indispensable for the
expulsion of helminths. Interleukin-17 (IL-17)-producing Th cells
(also known as Th17 cells) are critical for defending against
extracellular bacterial and fungal infections.
It usually takes several (5–10) days for antigen-specific CD4+
T cells to expand from rare precursors in the naive population
and reach a meaningful number to execute host defense func-378 Immunity 40, 378–388, March 20, 2014 ª2014 Elsevier Inc.tions. Therefore, many innate effector cells, including natural
killer (NK) cells, are responsible for early control of invading path-
ogens. Recently, a new class of innate effector cells whose
development relies on signaling through the IL-2 receptor
(IL-2R) common g chain and IL-7Ra has drawn much attention.
These cells, together with classical NK cells, are often referred
to as innate lymphoid cells (ILCs) (Sonnenberg and Artis, 2012;
Spits and Cupedo, 2012; Spits and Di Santo, 2011). Because
distinct subsets of ILCs are capable of making the same charac-
teristic effector cytokines as produced by different Th cell
subsets, they are similarly classified into type 1 ILCs (ILC1s),
including classical NK cells that produce interferon-g (IFN-g),
type 2 ILCs (ILC2s), which produce IL-5 and IL-13, and type 3
ILCs (ILC3s), including lymphoid tissue inducer (LTi) cells, which
produce IL-17 and IL-22 (Spits et al., 2013; Walker et al., 2013).
By producing Th2 cell effector cytokines such as IL-13, ILC2s
play an important role during early immune responses to hel-
minth infection (Fallon et al., 2006; Moro et al., 2010; Neill
et al., 2010; Price et al., 2010; Saenz et al., 2010). Mice with
dysfunctional ILC2s have a significant delay in worm expulsion
in Nippostrongylus brasiliensis infection, whereas expanding the
number of ILC2s by IL-25 injection can eliminate the need for
Th2 cells in effective resistance to helminth infection. ILC2s
are also important for allergen-induced airway inflammation
and lung-tissue repair in animal models (Chang et al., 2011;
Halim et al., 2012a; Monticelli et al., 2011), and human cells cor-
responding to the ILC2s found in mice have been identified
(Mjo¨sberg et al., 2011). The ILCs that produce IL-17 and IL-22
also participate in the early phase of responses to infections
and in inflammatory disorders (Buonocore et al., 2010; Lee
et al., 2012; Powell et al., 2012; Satoh-Takayama et al., 2008).
Thus, understanding the molecular mechanisms controlling
the development and functions of ILCs is essential to devel-
oping strategies to control responses to pathogens and
autoimmunity.
GATA3 is the key transcription factor for Th2 cell differentiation
(Yagi et al., 2011). GATA3 expression is indispensable for proper
induction of Th2 cytokines, including IL-4, IL-5, and IL-13, both
in vitro and in vivo (Zhu et al., 2004). Interestingly, GATA3 is crit-
ical not only for regulating Th2 cell differentiation but also for
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GATA3 Regulates IL-7Ra-Expressing ILC DevelopmentCD4+ T cell development in the thymus at multiple stages
(Ho et al., 2009; Pai et al., 2003; Ting et al., 1996).
It has been reported that GATA3 is highly expressed by ILC2
cells (Moro et al., 2010; Price et al., 2010). Conditional inactiva-
tion of Gata3 with a transgenic Cre whose expression is driven
by the Il13 locus completely eliminated IL-13-producing ILC2
cells (Liang et al., 2012). GATA3 has been shown to be critical
for the maintenance of ILC2 number and IL-13 production by
these cells both in mice and in humans (Furusawa et al., 2013;
Hoyler et al., 2012; Klein Wolterink et al., 2013; Mjo¨sberg et al.,
2012; Yang et al., 2013). However, because GATA3 affects
ILC2 number, IL-13 regulation by GATA3 in the previous studies
requires more careful assessment, i.e., at a single-cell level with
proper controls. Furthermore, other important target genes that
are regulated by GATA3 in ILC2s are largely unknown. Finally,
whether other ILC subsets require GATA3 to develop remains
unclear.
Here, we report that GATA3 is not only critical for T cell devel-
opment but also indispensable for the development of all the
IL-7Ra+ ILC lineages, including ILC2s, LTi cells, IL-7Ra-express-
ing NK cells, Nkp46+RORgt+ ILCs, and Nkp46+RORgt ILCs.
Both ILC2 progenitors and LTi progenitors were diminished
in the absence of GATA3. Genome-wide analysis of GATA3-
regulated genes in ILC2s and ILC3s suggested that GATA3
function during ILC development is independent of many known
key transcription factors, including Id2, RORa, RORgt, and Tcf7.
GATA3 regulated many critical genes, including Il5, Il13, Il1rl1,
Il2ra, Il9r, and Ccr8, but not Klrg1, in ILC2s. Comparing
GATA3-regulated genes in Th2 cells, we found that although
many genes, such as Pth, Cysltr1, Htr1b, and Tph1, were regu-
lated by GATA3 in a cell-type-specific manner, most of the key
type-2-immune-response-related genes were regulated by
GATA3 in both ILC2s and Th2 cells. These results demonstrate
that GATA3 plays parallel roles in regulating the development
and functions of CD4+ T cells and IL-7Ra+ ILCs, i.e., the develop-
ment of both CD4+ T cells and all IL-7Ra+ ILCs requires GATA3,
andGATA3 is especially critical for themaintenance and function
of ILC2s, similarly to in Th2 cells.
RESULTS
All ILCs Express GATA3 at Different Amounts
To determine the tissue distribution of ILCs (particularly ILC2s),
we assessed lineage-negative (Lin) CD127+ (IL-7Ra+) cells by
flow cytometry analysis of many lymphoid tissues and organs.
LinCD127+ cells represented <1% of the total cells in the
spleen, mesenteric lymph nodes, and the lung but were some-
what enriched in the small intestinal lamina propria (siLP,
Figure S1A, available online). Some of these ILCs were ILC2s,
identified by expression of T1/ST2 (IL-33R) (Moro et al., 2010;
Neill et al., 2010). ILC2s (T1/ST2+LinCD127+ cells) constituted
the largest fraction of recovered ILCs in the lung-derived cells
(>80% of total LinCD127+ cells, Figure S1B). In contrast, only
16% of LinCD127+ cells in the spleen were T1/ST2+. In the
mesenteric lymph nodes, 40% of the LinCD127+ cells were
T1/ST2+.
To assess GATA3 expression in the various subsets of ILCs,
weperformed ex vivoGATA3 intracellular staining of LinCD127+
cells harvested from different tissues. Most ILC2s expressedhigh levels of GATA3 whether they were from the spleen, mesen-
teric lymph nodes, lung, or siLP (Figure S1B). Interestingly, other
ILCs (T1/ST2LinCD127+ cells) expressed intermediate
amounts of GATA3. In the siLP,most of the LinCD127+GATA3int
cells were RORgt+ ILCs, and all LinCD127+GATA3hi cells
expressed another ILC2 marker (KLRG1), but not RORgt
(Figure S1C). Thus, all IL-7Ra ILCs expressed GATA3, albeit at
different amounts.
GATA3 Is Indispensable for the Development of All IL-
7Ra+ ILCs
To study the role of GATA3 in ILC development in vivo, we gener-
ated Gata3fl/fl-Vav-Cre mice in which Gata3 exon 4 was deleted
in hematopoietic stem cells. As expected, no T cells were
detected inGata3fl/fl-Vav-Cre mice (Figure 1A), confirming a pre-
vious report on the critical role of GATA3 in T cell development as
determined by germline Gata3 deletion (Ting et al., 1996). In
contrast, there was a modest but significant increase in B cells
in Gata3fl/fl-Vav-Cre mice (Figure 1A), arguing against a loss of
stem cell function. In line with a previous report showing that
GATA3 is critical for the development of IL-7Ra+ NK cells
(Vosshenrich et al., 2006), IL-7Ra+NK1.1+ cells, including
CD3εIL-7Ra+NK1.1+ cells, were absent in the spleen of
Gata3fl/fl-Vav-Cre mice, whereas classical IL-7RaNK1.1+ cells
were not significantly affected (Figure 1A). Staining of cells
from the lung of Gata3fl/fl-Vav-Cre mice showed complete
absence of ILC2s (Figure 1B). In the bone marrow of wild-type
mice, T1/ST2+ cells were detectable among the LinCD127+
population; these cells have been regarded as the progenitors
of ILC2s and they were all GATA3+ (Figure 1C). However, this
population was absent in the bone marrow of Gata3fl/fl-Vav-Cre
mice (Figure 1C). Overall, our data indicate that GATA3 is indis-
pensable for the development of ILC2s and T cells, but not B
cells or IL-7Ra NK cells.
We also noticed a defect in lymphoid organ development in
the Gata3fl/fl-Vav-Cre mice; similar to RORgt-deficient mice,
these mice had no lymph nodes, including the brachial and axil-
lary lymph nodes. This finding suggests that GATA3 regulates
the development of LTi cells, which are LinCD4+RORgt+ and
critical for the development of lymph node structure (Eberl
et al., 2004; Sun et al., 2000). Indeed, LinCD4+RORgt+ LTi cells,
which were found with a high frequency in the siLP of Gata3fl/fl
mice, were markedly reduced in theGata3fl/fl-Vav-Cre mice (Fig-
ure 2A). Furthermore, total LinRORgt+ cells were reduced in the
siLP of Gata3fl/fl-Vav-Cre mice (Figure 2B). In fact, IL-7Ra+ cells,
whether they expressed RORgt or not, were abolished in
Gata3fl/fl-Vav-Cre mice, suggesting that GATA3 is critical for
the development of all IL-7Ra-expressing ILCs. The loss of
RORgt+ ILCs was not due to a possible Cre-mediated genotox-
icity given that all the Gata3fl/+-Vav-Cre mice had normal lymph
node structure and developed RORgt+ ILCs normally (Figure S2).
LTi progenitors have been identified in the mouse fetal liver
(Cherrier et al., 2012; Possot et al., 2011). To assess the function
of GATA3 in the development of LTi progenitors, we stained fetal
liver cells from Gata3fl/fl-Vav-Cre embryos. LinCD127+ cells
were present at a similar frequency and total cell number be-
tween the Gata3fl/fl and Gata3fl/fl-Vav-Cre fetal livers (Figure 2C).
However, Flt3a4b7+CD127hi LTi progenitors were greatly
diminished in Gata3fl/fl-Vav-Cre fetal livers, suggesting thatImmunity 40, 378–388, March 20, 2014 ª2014 Elsevier Inc. 379
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Figure 1. GATA3 Is Critical for the Development of T Cells and ILC2s,
but Not B Cells and Classical NK Cells
(A) Total splenocytes from Gata3fl/fl or Gata3fl/fl-Vav-Cre mice (three mice per
group) were stained for CD3ε, CD4, CD19, B220, NK1.1, and CD127. Dot plots
(left panel) and total numbers of T, B, and NK cells (right panel) are shown.
(B) Cells prepared from the lungs of Gata3fl/fl or Gata3fl/fl-Vav-Cre mice (three
mice per group) were stained with a cocktail of antibodies to CD127, T1/ST2,
and various lineage markers. Dot plots gated on Lin cells (left panel) and total
numbers of lung ILC2s (right panel) are shown.
(C) Cells prepared from the bone marrow ofGata3fl/fl orGata3fl/fl-Vav-Cre mice
(three mice per group) were stained with a cocktail of antibodies to CD127, T1/
ST2, GATA3, and various lineage markers. Dot plots gated on Lin (left panel)
and total numbers of ILC2 progenitors in the bone marrow (right panel) are
shown.
Numbers indicate the percentages in each box or quadrant. Error bars
represent the mean ± SD. ns, not significant. *p < 0.05. Data are representative
of three independent experiments. See also Figure S1.
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GATA3 Regulates IL-7Ra-Expressing ILC DevelopmentGATA3 is critical for the development of such cells. Together with
the finding that GATA3 is required for the generation of ILC2 pro-
genitors in bone marrow (Figure 1C), our data suggest that380 Immunity 40, 378–388, March 20, 2014 ª2014 Elsevier Inc.GATA3 might act in a common innate lymphoid progenitor
(CILP) that gives rise to all IL-7Ra-expressing ILCs.
IL-7Ra ILCs found in the compartment of intraepithelial lym-
phocytes (IELs) have been reported, and these cells express
both NK1.1 and Nkp46 (Fuchs et al., 2013). Interestingly, there
were significantly more IEL ILCs in Gata3fl/fl-Vav-Cre mice than
in Gata3fl/fl mice (Figure 2D), indicating that GATA3 is critical
for the development of IL-7Ra+ ILCs, but not IL-7Ra ILCs.
Gata3fl/fl-Vav-Cre Mice Are Susceptible to Citrobacter
rodentium Infection
IL-7Ra+ ILCs also include IL-22-producing ILCs, some of which
express Nkp46. These cells play a critical role in host defense
against Citrobacter rodentium infection. Thus, we tested
whether Gata3fl/fl-Vav-Cre mice are susceptible to Citrobacter
rodentium infection. On day 4 after infection, a substantial num-
ber of LinIL-7Ra+ cells, many of which expressed Nkp46, were
detected in the large intestinal lamina propria (liLP) of littermate
mice (Figures 3A and 3B); these cells were absent in the liLP of
the Gata3fl/fl-Vav-Cre mice. Accordingly, Gata3fl/fl-Vav-Cre
mice had much higher bacterial load than their littermates (Fig-
ure 3C). All of the Gata3fl/fl-Vav-Cre mice died after Citrobacter
rodentium infection, whereas all of the control mice survived
(Figure 3D). These data further establish the role of GATA3 in
the development of IL-22-producing ILCs.
TheEffect of GATA3on theDevelopment of IL-7Ra+ ILCs
Is Cell Intrinsic
Vav-Cre deletes floxed genes specifically in hematopoietic stem
cells; therefore, the failure of ILC development in Gata3fl/fl-Vav-
Cre mice is not due to a GATA3 function in nonhematopoietic
cells. To further confirm this, we performed mixed bone marrow
chimera experiments to directly examine whether the influence
of GATA3 on ILC development is cell intrinsic. As expected,
GATA3-sufficient and -deficient bone marrow cells efficiently
repopulated CD45+ cells in the spleen of Rag2/Il2rg/ mice
(Figure 4). However, GATA3-deficient bone marrow cells failed
to give rise to IL-7Ra+ ILCs in the mixed bone marrow chimeras.
In contrast, B cells developed normally, whereas T cells failed to
develop from GATA3-deficient bone marrow progenitors. These
results indicate that the effect of GATA3 on the development of
IL-7Ra+ ILCs is cell intrinsic.
GATA3 Is Required for Maintaining ILC2 Number Both
In Vivo and In Vitro
At first consideration, our results contradict an earlier report
showing that GATA3 is required for the development of ILC2s,
but not other ILCs (Hoyler et al., 2012). However, in that study,
Gata3 was deleted by an inducible Cre driven by the Id2 locus
after all the ILCs had fully developed. Therefore, it is likely that
the survival of ILC2s is sensitive to Gata3 deletion. To test this
possibility, we generated Gata3fl/fl-CreERT2 mice and treated
them with tamoxifen. Three weeks after treatment, we observed
that only KLRG1+ ILC2s, but not RORgt+ ILCs, in the siLP were
diminished (Figure 5A), confirming that GATA3 is critical only
for the maintenance of ILC2s in vivo.
Because GATA3 is required for the development and mainte-
nance of ILC2s in vivo, it is difficult to assess the function of




Figure 2. GATA3 Is Critical for the Development of All IL-7Ra+ ILCs,
but Not IL-7Ra– ILCs
(A) Cells prepared from the siLP of Gata3fl/fl or Gata3fl/fl-Vav-Cre mice (three
mice per group) were stained with a cocktail of antibodies to CD4, RORgt, and
various lineage markers. Plots gated on Lin cells (left panel) and total
numbers of LTi cells (right panel) are shown.
(B) Cells prepared from the siLP of Gata3fl/fl or Gata3fl/fl-Vav-Cre mice (three
mice per group) were stained with a cocktail of antibodies to CD127, RORgt,
and various lineage markers. Plots gated on Lin cells (left panel) and total
numbers of IL-7Ra+ ILCs (right panel) are shown.
(C) Fetal liver common lymphoid progenitors (CLPs, LinCD127+) from Ga-
ta3fl/fl (n = 6) or Gata3fl/fl-Vav-Cre (n = 2) embryos at embryonic day 15.5 were
fractionated by the expression of Flt3 and a4b7. Plots were gated on Lin cells
(upper left panels) or LinCD127+ cells (upper middle and right panels). Total
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GATA3 Regulates IL-7Ra-Expressing ILC DevelopmentILC2s, although present at a low frequency, expand during
type 2 immune responses, presumably as a result of stimula-
tion by IL-25 and/or IL-33, which are produced by epithelial
cells. Indeed, injection of IL-25 induced substantial expansion
of ILC2s (Neill et al., 2010; Saenz et al., 2013). We also
observed that IL-25 injection induced the expansion of ILC2s.
Culturing sorted Lin cells harvested from mesenteric lymph
nodes of IL-25-injected mice with IL-33, IL-25, and IL-7
in vitro further expanded these cells. After 5–7 days of culture
of purified Lin cells, virtually all cells were GATA3hi
(Figure S3A). These cells also expressed two cell-surface mol-
ecules, Sca-1 and KLRG1, which are highly expressed by
ILC2s (Figures S3B and S3C). Therefore, we chose this
approach in an effort to obtain large numbers of ILC2s at
high purity; staining and/or sorting for T1/ST2- and IL-7Ra-ex-
pressing cells was not required until the end of the culture, alle-
viating the concern that antibody staining might affect IL-33 or
IL-7 signaling.
To determine the function of GATA3 in ILC2s, we prepared
ILC2s, as described in Figure S3, from Gata3fl/fl-CreERT2 or
Gata3fl/fl mice. After 5 days of culture, samples were split into
two groups and treated either with 4-hydroxytamoxifen (4-OHT),
the activemetabolite of tamoxifen that binds toCreERT2 to induce
Cre activity, or with a vehicle control, ethanol (EtOH). To test
whether GATA3 affects ILC2 maintenance in culture in a cell-
intrinsic manner, we mixed Gata3fl/fl-CreERT2 or Gata3fl/fl ILC2s
with ILC2s generated from CD45.1 congenic mice. After 4-OHT
treatment, there was a progressive decrease in the percentage
of Gata3-deficient ILC2s over a 6-day period (Figure 5B). To
comprehensively profile the genes regulated by GATA3 in ILC2s
at a genome-wide level, we sorted live ILC2s that had or had
not undergone Gata3 inactivation on day 2, a time point when
no dramatic ILC2 loss was observed, and performed RNA
sequencing (RNA-seq) analyses. Interestingly, we found that
many TNF and TNFR superfamily genes, such as Tnfrsf9 (encod-
ing 4-1BB, which provides costimulation) and Tnfsf21 (encoding
DR6, which induces cell apoptosis), and NFKb family members,
including Nfkb2 and Relb, showed altered expression patterns
(Figure 5C). In addition, the cell-cycle inhibitor Cdkn2b was
upregulated upon Gata3 inactivation (Figure 5C). These
changes are consistent with and might contribute to the loss of
Gata3-deficient ILC2s.
GATA3 Regulates Many Critical Genes in ILC2s and Th2
Cells
RNA-seq results confirmed efficient Gata3 inactivation by Cre-
ERT2 after 4-OHT treatment given that a nearly 100% reduction
of the reads at Gata3 exon 4 was observed (Figure 6A). Interest-
ingly, reads at the other exons of Gata3 were only modestlynumbers of CLPs (LinCD127+ cells) and LTi progenitors (LinCD127+
Flt3a4b7+CD127hi cells) were calculated (lower panels).
(D) Intraepithelial lymphocytes (IELs) prepared from Gata3fl/fl or Gata3fl/fl-Vav-
Cre mice (three mice per group) were stained with a cocktail of antibodies to
CD45, NK1.1, Nkp46, and various lineagemarkers. Plots gated on CD45+ cells
(left panel) and total numbers of IEL ILCs (right panel) are shown.
Numbers indicate the percentages in each box. Error bars represent the
mean ± SD. ns, not significant. *p < 0.05. Data are representative of three
(A and B) or two (C and D) independent experiments. See also Figure S2.
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Figure 3. GATA3 Deficiency Results in Susceptibility to Citrobacter
rondentium Infection
Gata3fl/fl or Gata3fl/fl-Vav-Cre mice (three to four mice per group) were orally
infected with Citrobacter rondentium. Four days after infection (A–C), cells
were harvested from the large intestinal lamina propria (liLP) and stained with a
cocktail of antibodies to CD127, RORgt, Nkp46, and various lineage markers.
Data in (A)–(C) represent one experiment, and data in (D) represent another
experiment. Error bars represent the mean ± SD. Numbers indicate the
percentages in each quadrant or gate.
(A) Plots were gated on Lin cells (left panel) or LinCD127+ cells (right panel).
(B) The absolute number of Nkp46+ populations from the liLP of each mouse
was plotted.
(C) Feces were collected for assessing bacterial loads.
(D) Survival curves are shown for the Gata3fl/fl or Gata3fl/fl-Vav-Cre mice after
infection.
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GATA3 Regulates IL-7Ra-Expressing ILC Developmentaffected, implying that GATA3 is not amajor player inmaintaining
its own transcription in ILC2s (Figure 6A).
We then compared genes that are either positively or nega-
tively regulated by GATA3 in ILC2s and Th2 cells (Wei et al.,
2011). A total of 32 genes that are positively regulated by
GATA3 in Th2 cells were also affected in ILC2s uponGata3 inac-
tivation (Figures 6B and 6C and Table S1). Il13 transcripts were
dramatically reduced when GATA3 was absent in ILC2s (Fig-
ure 6C and Table S1). Other genes that are positively regulated
by GATA3 in both ILC2s and Th2 cells include Areg (encoding
Amphiregulin), Il5, Ccr8, and Lif (Figure 6C and Table S1). Inter-
estingly, Il1rl1 (encoding IL-33R) and Il9r were expressed at
much higher levels in ILC2s than in Th2 cells; their expression
was dramatically reduced when Gata3 was disrupted in ILC2s
(Figure 6C and Table S1).
We also identified 225 genes, including Il4,Maf, Pth, and Ikzf3
(encoding Aiolos), that are positively regulated by GATA3 in Th2
cells but that are not affected by GATA3 in ILC2s (Figure 6B). On
the other hand, 130 genes are positively regulated by GATA3 in
ILC2s, but not in Th2 cells; they include Icos, Il2ra, Kit, Il1r2,
Cysltr1,Htr1b, and Tph1, many of which are cell-surfacemarkers382 Immunity 40, 378–388, March 20, 2014 ª2014 Elsevier Inc.of ILC2s (Figures 6B and 6D and Table S1). These data indicate
that GATA3 has unique functions in ILC2s and Th2 cells in addi-
tion to its common regulation of many type 2 effector cytokines.
Gata3 inactivation in Th2 cells resulted in derepression of
several Th1-cell-associated genes, such as Fasl, Il12rb2, and
Stat4 (Table S1). However, Gata3 inactivation in ILC2s did not
alter the expression of these genes; instead, it derepressed
several other genes—such as Cd244 (encoding 2B4), Lta, and
Tnf (Figure 6E and Table S1)—that are characteristic of type I
ILCs and/or NK cells.
Gata3 inactivation did not reduce Klrg1 transcription (Fig-
ure 6F), suggesting that Klrg1 is not a GATA3 target gene. Other
cell-surface molecules expressed by ILC2s include CD127,
Sca-1, and Thy1. The expression of Il7r (encoding CD127) and
Ly6a/e (encoding Sca-1) was reduced less than 2-fold, whereas
Thy1 expression was increased upon Gata3 inactivation (Table
S1). The expression of Rora and Id2, encoding two transcription
factors critical for the development of ILC2s, was not reduced
upon Gata3 inactivation (Figure 6F).
To determine whether GATA3 has a similar function in ILC2s at
the steady state, we performed RNA-seq by using ex-vivo-puri-
fied KLRG1+ ILC2s from tamoxifen-treated Gata3fl/fl or Gata3fl/fl-
Cre-ERT2 mice. The results indicated that among the 162 genes
positively regulated by GATA3 in activated ILC2s, 57 genes were
also positively regulated by GATA3 in ‘‘naive’’ ILC2s (Figure 6G
and Table S1). These included Il5, Il13, Areg, Il1r1, Ccr8, Il2ra,
Cysltr1, Tph1, and Htr1b. Interestingly, Il10 and Il24 were regu-
lated by GATA3 in activated ILC2s, but not in ‘‘naive’’ ILC2s
(Figure 6G), suggesting that GATA3-mediated regulation of Il10
and Il24 expression requires cofactors that are only present in
activated ILC2s. Il4 expression was affected by Gata3 deletion
in ‘‘naive’’ ILC2s, but not in activated ILC2s (Figure 6G), consis-
tent with our previous finding that GATA3 is required for the
expression of IL-4 in developing Th2 cells but is not essential
in fully differentiated Th2 cells.
To verify the RNA-seq data at the protein level, we performed
flow cytometry analysis. Compared to control samples, 4-OHT-
treated Gata3fl/fl-CreERT2 ILC2 culture showed no evidence of
GATA3 expression, as judged by intracellular staining (Fig-
ure S4A), implying that the deletion of Gata3 was efficient and
the pre-existing GATA3 was degraded in ILC2s over a 2-day
period. By contrast, consistent with the RNA-seq data, two
cell-surface molecules highly expressed by ILC2s (KLRG1 and
Sca-1) were only modestly, if at all, affected by inactivation of
Gata3 (Figures S4B and S4C), demonstrating that ILC2s main-
tain some features of their phenotype in the absence of
GATA3. Consistent with the role of GATA3 in Th2 cells, IL-13 pro-
duction by ILC2s in response to IL-33 and IL-7 stimulation was
dramatically reduced upon Gata3 inactivation (Figure S4D). In
agreement with RNA-seq data, T1/ST2 surface expression was
also abolishedwhenGata3was inactivated in ILC2s (Figure S4E).
This result raised the question of whether defective expression of
IL-13 was due to a failure of the Gata3-deficient cells to respond
to IL-33 or to a direct effect of GATA3 on Il13. Therefore, we
stimulated these cells with PMA and ionomycin. Even with this
potent stimulus, IL-13 production was dramatically decreased
in Gata3-deficient cells (Figure S4F), suggesting that GATA3
directly regulates IL-13 production in ILC2s independently of
its role in maintaining IL-33R expression. This is consistent
Figure 4. The Effect of GATA3 on the Devel-
opment of IL-7Ra+ ILCs Is Cell intrinsic
Bone marrow cells from Gata3fl/fl or Gata3fl/fl-Vav-
Cre mice were mixed with bone marrow cells from
CD45.1 congenic mice (line 7) and cotransferred
into irradiated Rag2/Il2rg/ mice. Eight weeks
after mixed bone marrow transplant, cells were
harvested from the spleen or siLP of chimeric mice
(three mice per group) and stained with CD45.1
and CD45.2 together with a cocktail of antibodies
to CD127 and various lineage markers. Plots were
gated on total splenocytes (upper panel) or
LinCD127+ cells from the siLP (lower panel). The
ratio of CD45.2 to CD45.1 was calculated and is
shown on the right. Numbers indicate the per-
centages in each box. Error bars represent the
mean ± SD. ns, not significant. *p < 0.05.
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promoter of Il13 in many T cell subsets (Wei et al., 2011).
GATA3 Regulates Common and Unique Sets of Genes in
ILC2s and ILC3s
To determine the GATA3 target genes in ILC3s, we performed
RNA-seq on ILC3s with or without Gata3 deletion. Ninety-eight
and 81 genes were positively and negatively regulated, respec-
tively, by GATA3 in ILC3s. Among the 98 positively regulated
genes, 29 (including Atf3,Ccr9, Ets2, andNr4a2) were also posi-
tively regulated by GATA3 in ILC2s (Figure 7A and Table S1).
Similarly, among the 81 negatively regulated genes, 17 were
also negatively regulated by GATA3 in ILC2s. The functions of
these 46 genes that were commonly regulated by GATA3 in
ILC2s and ILC3s require further investigation. Many more genes
are regulated byGATA3 in ILC2s than in ILC3s, possibly because
GATA3 is expressed at much higher amounts in ILC2s than in
ILC3s. Some cytokine-receptor-encoding genes regulated by
GATA3 in ILC2s (such as Il1rl1, Il2ra, and Il9r) were not regulated
by GATA3 in ILC3s. The expression of key transcription-factor-
encoding genes reported to be critical for the development of
ILC3s, including Rorc, Runx1, Runx3, Ahr, Id2, and Tcf7, was
not affected by Gata3 deletion in ILC3s (Figure 7B). Together
with the finding that GATA3 does not affect the expression of
Id2 and Rora in ILC2s (Figure 6F), our data indicate that the
mechanism of GATA3 in regulating the development of IL-
7Ra-expressing ILCs is independent of, or in parallel with, all
known key transcription factors.
DISCUSSION
Research on the ILCs has exploded since the description and
characterization of the ILC2s in 2010 by four different groups
(Moro et al., 2010; Neill et al., 2010; Price et al., 2010; Saenz
et al., 2010), and it is now well accepted that ILCs play important
roles in innate immunity by producing effector cytokines (Spits
et al., 2013). Because these effector cytokines are virtually iden-
tical to those produced by Th cells, ILCs can be divided into
ILC1s, ILC2s, and ILC3s, representing innate versions of Th1-,
Th2-, and Th17-like cells, respectively (Spits et al., 2013). There
are also similarities in the development of ILCs and Th cellsbecause the key transcription factor that determines a particular
Th cell fate is also critically involved in the development of its ILC
counterpart (Bernink et al., 2013; Eberl et al., 2004; Hoyler et al.,
2012; Klose et al., 2013; Mjo¨sberg et al., 2012; Sciume´ et al.,
2012; Spits et al., 2013; Vonarbourg et al., 2010). However,
much less is known about the early development of ILCs. Our
observation that the development of all IL-7Ra+ ILCs, but not
classical NK cells, requires GATA3 suggests that all IL-7Ra+
ILC subsets might have a CILP. Furthermore, by comparing
gene expression in mature ILC2s with or without GATA3 expres-
sion at a genome-wide level, we have provided important data
that are crucial for further understanding the development and
functions of ILC2s during type 2 immune responses.
Previous reports have suggested that ILC2s can be identified
by a combination of several cell-surface markers, including T1/
ST2 (IL-33R), IL-25R, ICOS, Sca-1, and KLRG1, in addition to
IL-2Ra and IL-7Ra (Halim et al., 2012b; Hoyler et al., 2012;
Moro et al., 2010; Neill et al., 2010; Price et al., 2010; Saenz
et al., 2010; Wong et al., 2012). We have shown that GATA3
regulates most of these molecules. However, the expression
of IL-7Ra and Sca-1 is only modestly reduced, and KLRG1 is
not affected by Gata3 inactivation. We also identified other
cell-surface molecules, including IL-9R, CCR8, cysteinyl leuko-
triene receptor 1 (Cysltr1), 5-hydroxytryptamine (serotonin) re-
ceptor 1B (Htr1b), and TNFR superfamily members 4-1BB and
RANK, whose expression in ILC2s is GATA3 dependent, in addi-
tion to known ILC2 cell-surface markers. Cysltr1 is expressed by
ILC2s, and leukotriene D4 is able to induce the expression of
IL-5, IL-13, and IL-4 (Doherty et al., 2013). Therefore, GATA3
might indirectly affect type 2 cytokine production in vivo by regu-
lating two stimulating receptors, T1/ST2 and Cysltr1. Overall, our
data indicate that although GATA3 regulates many of the distin-
guishing cell-surface markers on ILC2s, other transcription fac-
tors are also involved. Identification of other factors that regulate
KLRG1 expression might add important insights into the tran-
scription factor networks controlling the development andmatu-
ration of ILC2s.
GATA3 plays critical roles in the differentiation and mainte-
nance of both Th2 cells and ILC2s and thus is important for medi-
ating type 2 immune responses at different stages. Through
genome-wide profiling of the genes regulated by GATA3 inImmunity 40, 378–388, March 20, 2014 ª2014 Elsevier Inc. 383
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Figure 5. GATA3 Is Critical for the Mainte-
nance of ILC2 Numbers Both In Vivo and
In Vitro
(A)Gata3fl/fl orGata3fl/fl-CreERT2mice (two to three
mice per group) were intraperitoneally injected five
times with tamoxifen every other day. Three weeks
after the first injection, siLP cells were prepared
and stained with a cocktail of antibodies to CD127
(IL-7Ra), KLRG1, RORgt, and various lineage
markers. Plots were gated on live cells (left panel)
or LinCD127+ cells (right panel). Numbers indi-
cate the percentages in each quadrant.
(B) Lin cells were purified from the mesenteric
lymph nodes of IL-25-treated Gata3fl/fl-CreERT2,
Gata3fl/fl, andCD45.1 congenic (line 7)mice (two to
three mice per group) by cell sorting. After being
cultured with IL-7, IL-25, and IL-33 for 5 days, they
were mixed as indicated at a 1:1 ratio and then
treated with 4-hydroxytamoxifen (4-OHT). The
relative cell numbers were calculated on the basis
of the change in ratio over a period of 6 days. Four
independently mixed cultures were tested in both
groups. Data are representative of two indepen-
dent experiments.
(C) Lin cells were purified from the mesenteric
lymph nodes of IL-25-treated Gata3fl/fl-CreERT2
mice (two to threemice per group in duplicates) by cell sorting. After being cultured with IL-7, IL-25, and IL-33 for 5 days, they were then treated with either 4-OHT
or ethanol (EtOH) for 2 days. RNA-seq analysis was carried out. Relative mRNA expression of several genes was calculated on the basis of the RNA-seq results
with duplicates.
Error bars represent the mean ± SD. See also Figure S3.
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GATA3 in Th2 cells and in ILC2s. Most strikingly, these
commonly regulated genes included many key effector cyto-
kines and receptors, such as Il13, Il5, Areg, Il10, Il24, Lif, Il1rl1,
Il9r, and Ccr8. Except for Il10 and Il24, which were expressed
only in activated ILC2s, all other key cytokines and receptors
were also regulated by GATA3 in ‘‘naive’’ ILC2s at the steady
state. IL-4 was regulated by GATA3 in ‘‘naive’’ ILC2s, but not
cultured ILC2s, consistent with our previous findings in T cells
that GATA3 is important for the induction of IL-4 during Th2
cell differentiation but plays a minor role in IL-4 production in
already developed Th2 cells. Thus, our data indicate that ILC2s
resemble the innate counterpart of Th2 cells at a genomic scale
and that GATA3 regulates the key functions shared by ILC2s and
Th2 cells, possibly through a similar mechanism.
GATA3 is thought to be critical for controlling the cell fate of
ILC2s, but not other ILCs (Hoyler et al., 2012). The discrepancy
between this report and our study can be explained by the
timing of Gata3 inactivation. In that study, Id2-driven Cre-ERT2
was used for conditional deletion of Gata3 by tamoxifen
in otherwise normal mice. Because all the ILCs had already
developed in these mice before Gata3 inactivation and the
half-life of ILCs might be longer than 3 weeks, the specific effect
on ILC2s 3 weeks after GATA3 removal only confirms that
GATA3 is critical for the maintenance of ILC2s, but not other
ILCs. Indeed, we were also able to show that tamoxifen-
induced Gata3 deletion in Gata3fl/fl-CreERT2 mice abolished
ILC2s but had no effect on RORgt+ ILCs once they had devel-
oped. Therefore, acute Gata3 ablation after ILCs have devel-
oped obscures the role we have revealed here for GATA3 during
development of ILCs. Vav-Cre-mediated gene inactivation dis-384 Immunity 40, 378–388, March 20, 2014 ª2014 Elsevier Inc.rupted Gata3 before ILCs could develop, allowing us to
conclude that GATA3 is critical for the development of all
IL-7Ra+ ILCs, including ILC2s.
All known subsets of ILCs and NK cells depend on Id2 expres-
sion for their development (Moro et al., 2010; Yokota et al., 1999).
Although E4BP4 (also known as NF-IL3) is critical for the devel-
opment of NK cells (Gascoyne et al., 2009; Kamizono et al.,
2009), no severe ILC developmental defect has been reported
in E4BP4-deficient mice. For the development of IL-7Ra+ ILC
subsets, RORa is a transcription factor specifically required for
inducing ILC2s (Halim et al., 2012b; Wong et al., 2012), but not
RORgt-expressing ILCs (Halim et al., 2012b). On the other
hand, RORgt is only needed for the development of RORgt-ex-
pressing ILCs (Eberl et al., 2004; Halim et al., 2012b), but not
ILC2s (Halim et al., 2012b; Moro et al., 2010). Up until now, the
transcription factor critical for the development of all IL-7Ra+
ILC lineages, but not NK cells, has not been identified. Here,
we report that GATA3 is such a transcription factor. GATA3
does not seem to regulate Id2, RORa, or RORgt, suggesting
that GATA3 might collaborate with Id2 for ILC development in
general, with RORa for ILC2 development, and with RORgt for
ILC3 development. Our data indicate that different IL-7Ra+ ILC
subsetsmight develop through aGATA3-dependent mechanism
from a common progenitor. Thus, a hematopoietic branch point,
with E4BP4 committing progenitors to the NK cell lineage and
GATA3 leading to the development of IL-7Ra+ ILCs, might exist.
Therefore, it is reasonable to consider that IL-7Ra+ ILC subsets
resemble innate version of CD4+ Th cell subsets, whereas con-
ventional NK cells, which have higher cytotoxic activity than







Figure 6. GATA3 Positively and Negatively
Regulates the Expression of Many Critical
Genes in ILC2s
(A–F) Lin cells were purified from the mesenteric
lymph nodes of IL-25-treated Gata3fl/fl-CreERT2
mice (two to three mice per group in duplicates) by
cell sorting. After being cultured with IL-7, IL-25,
and IL-33 for 5 days, they were then treated with
either 4-OHT or EtOH for 2 days. (A) UCSC
Genome Browser view of the RNA-seq data at the
Gata3 locus (left panel). The boxed area indicates
the deletion of exon 4 by Cre-ERT2. Relative Gata3
mRNA expression was calculated on the basis of
the RPKM (reads per kilobase of exon per million
reads) values obtained from RNA-seq results with
duplicates (right panel). (B) Venn diagrams show
the overlap of total genes positively (upper) or
negatively (lower) regulated by GATA3 in ILC2s
and Th2 cells. (C–F) Representative genes regu-
lated by GATA3 in different categories are shown.
Relative mRNA expression was calculated on the
basis of the RPKM values obtained from RNA-seq
results with duplicates. (C) Examples represent 32
genes positively regulated by GATA3 in both ILC2s
and Th2 cells. (D) Examples represent 130 genes
positively regulated by GATA3 in ILC2s, but not in
Th2 cells. (E) Examples represent 151 genes
negatively regulated by GATA3 in ILC2s, but not in
Th2 cells. (F) Expression of Klrg1, Id2, and Rora
was not affected by Gata3 inactivation in ILC2s.
(G) Gata3fl/fl or Gata3fl/fl-CreERT2 mice (four mice
per group) were treated with tamoxifen in vivo for 2–3 days, and then ILC2s were sorted on the basis of KLRG1 expression. RNA-seq analyses were performed
withGata3-sufficent and Gata3-deficient cells. The Venn diagram shows the overlap of total genes positively regulated by GATA3 in cultured ILC2s and ILC2s at
the steady state.
Error bars represent the mean ± SD. See also Figure S4 and Table S1.
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GATA3 Regulates IL-7Ra-Expressing ILC DevelopmentOur study shows that there is an excellent symmetry in ILC and
Th cell development: although GATA3 is regarded as the master
regulator for Th2 cells, it is also critical for the maintenance and
functions of ILC2s, and although GATA3 is critical for the devel-
opment of all CD4+ T cells (Ho et al., 2009), it is also indispens-
able for the development of all IL-7Ra+ ILC subsets. GATA3,
therefore, plays parallel roles in establishing and regulating
both adaptive and innate lymphocyte populations.EXPERIMENTAL PROCEDURES
Mice
Gata3fl/fl mice on a C57BL/6 background were previously described (Yagi
et al., 2010). These mice were bred with either CreERT2 (Taconic line 10471)
or Vav-Cre (The Jackson Laboratory line 8610) transgenic mice on a C57BL/
6 background for the generation of Gata3fl/fl-CreERT2 or Gata3fl/fl-Vav-Cre
lines. C57BL/6 mice were ordered from Taconic. CD45.1 congenic mice (line
7) and Rag2/Il2rg/mice (line 4111) were from a contract between Taconic
and the National Institute of Allergy and Infectious Diseases (NIAID). All mice
were bred and/or maintained in the NIAID-specific pathogen-free animal facil-
ity, and the experiments were done when mice were 8 to 16 weeks of age un-
der protocols approved by the NIAID Animal Care and Use Committee.
Citrobacter rodentium Infections
Citrobacter rodentium (formerly Citrobacter freundii, biotype 4280) strain
DBS100 was prepared by selection of a single colony and culture in Luria-
Bertani broth for 8 hr. Mice were inoculated with approximately 1 3 1010 col-
ony-forming units (cfu) in 200 ml of PBS via oral gavage. Cells from the liLP
were prepared as previously described (Sun et al., 2007). cfu were deter-mined via serial dilutions on MacConkey’s agar from overnight cultures of
homogenized fecal pellets.
Cell Preparation
Single-cell suspensions were prepared directly from mouse fetal livers or
different lymphoid organs, including lymph nodes, spleen, and bone marrow.
Cells from the siLP and IELs were prepared as previously described (Sun et al.,
2007). For preparing cells from tissues such as lung, mice were perfused with
PBS before organs were harvested. The lung was cut into small pieces and
digested with DNase I (Roche) and Liberase (Roche) for 30 min at 37C.
Single-cell suspension from digested lung was subjected to Percoll density
gradient centrifugation. In some experiments, recombinant murine IL-25
(from either eBioscience or PeproTech, 0.4 mg per mouse) in PBS was injected
intraperitoneally into mice for 3 consecutive days before mesenteric lymph
nodes were harvested. In other experiments, tamoxifen (Sigma) was intraper-
itoneally injected five times into mice every other day (5 mg tamoxifen in 150 ml
corn oil per mouse per injection). In mixed bone marrow chimera experiments,
bone marrow cells from Gata3fl/fl or Gata3fl/fl-Vav-Cre mice were mixed with
bone marrow cells from CD45.1 congenic mice (line 7) at a 1:1 ratio and
injected (10 million cells per mouse) into sublethally irradiated (450 Rad)
Rag2/Il2rg/ mice (line 4111). Cells were stained with a cocktail of anti-
bodies to various lineage markers, including antibodies to CD3, CD5,
CD45R, CD11b, CD11c, NK1.1, Gr-1, TER119, FcεRI, and TCRg/d for identi-
fying Lin cells. Lin cells were sorted with a FACS Aria and then cultured
with IL-7 (10 ng/ml), IL-33 (10 ng/ml), and IL-25 (10 ng/ml) for 1 week. In
some experiments, cells were treated with 100 nM 4-OHT after 5 days of cul-
ture for the deletion of Gata3 from Gata3fl/fl-CreERT2 cells.
Flow Cytometry Analysis
Cell-surface molecule staining and cytokine intracellular staining were per-
formed as previously described (Zhu et al., 2004). Staining for transcriptionImmunity 40, 378–388, March 20, 2014 ª2014 Elsevier Inc. 385
AB
Figure 7. GATA3 Does Not Regulate Known Key Transcription Fac-
tors in ILC3s
(A) Gata3fl/fl or Gata3fl/fl-CreERT2 mice (four mice per group) were treated with
tamoxifen in vivo for 2–3 days, and then KLRG1 ILCs (mostly ILC3s) were
sorted. RNA-seq analyses were performed with Gata3-sufficent and Gata3-
deficient ILC3s. RNA-seq analyses were also performed with Gata3-sufficent
and Gata3-deficient ILC2s, as described in Figure 6G. The Venn diagram
shows the overlap of total genes positively or negatively regulated byGATA3 in
ILC2s and ILC3s.
(B) Expression of Rorc, Runx1, Runx3, Id2, Ahr, and Tcf7 was not affected by
Gata3 inactivation in ILC3s. Error bars represent the mean ± SD.
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GATA3 Regulates IL-7Ra-Expressing ILC Developmentfactors was carried out with the Foxp3 Staining Buffer Set (eBioscience) ac-
cording to the manufacturer’s instructions. Flow cytometry data were
collected with the LSR II (BD Biosciences), and the results were analyzed
with FlowJo software (Tree Star). Antibodies specific to mouse CD5 (53-7.3),
CD45R (RA3-6B2), Gr-1 (RB6-8C5), NK1.1 (PK136), and TCRg/d (UC7-13D5)
and a mouse erythroid cell marker (TER119) were purchased from BioLegend;
antibodies specific to mouse CD3 (2C11), CD4 (RM4-5), CD11b (M1/70),
CD11c (N418), CD127 (A7R34), CD45.1 (A20), CD45.2 (104), FcεRI (MAR-1),
IL-13 (eBio13A), KLRG1 (2F1), NKp46 (29A1.4), RORgt (AFKJS-9), Sca-1
(D7), Flt3 (A2F10), a4b7 (DATK32), and c-Kit (2B8) were purchased from eBio-
sciences; antibodies specific to Thy1.2 (53-2.1) and GATA3 (L50-823) were
purchased from BD Biosciences; and antibodies specific to IL-33R (DJ8)
were purchased from MD Bioproducts.RNA-Seq and Data Analysis
Lin cells were sorted fromGata3fl/fl-CreERT2 mice that had been injected with
IL-25 for 3 days. After 5-day culture in IL-7, IL-25, and IL-33, cells were treated
with either 4-OHT or EtOH as a control for 2 days.Gata3-sufficient ILC2s were
sorted from EtOH-treated samples. Gata3-deficient cells were sorted from
4-OHT-treated samples, excluding residual T1/ST2-expressing cells. In other
experiments, Gata3fl/fl or Gata3fl/fl-CreERT2 mice were injected with tamoxifen
(5 mg/mouse). After 2–3 days, LinThy1+CD127+KLRG1+ cells (mostly ILC2s)
and LinThy1+CD127+KLRG1 cells (mostly ILC3s) were sorted from the siLP.
RNA-seq experiments were performed. In brief, 100 ng of total RNAwas ampli-
fied with the Ovation RNA-Seq System V2 (NuGEN). The resulting double-
stranded DNA was sonicated to 200–400 bp. Two hundred fifty nanograms
of sonicated DNA was used for preparing sequencing libraries for multiplex
sequencing (Illumina), and 50 bp reads were generated by the NHLBI DNA
Sequencing and Computational Biology Core. Sequencing reads were map-
ped to the mm9 genome (UCSC Genome Browser). Gene expression levels
were measured by RPKM (reads per kilobase of exon per million reads) in
the library (Mortazavi et al., 2008). Differentially expressed genes were identi-
fied by edgeR (Robinson et al., 2010) with the following criteria: false discovery386 Immunity 40, 378–388, March 20, 2014 ª2014 Elsevier Inc.rate < 0.001, fold change > 2, and RPKM > 3 in eitherGata3-sufficient or -defi-
cient samples.
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RNA-seq data are available in the Gene Expression Omnibus (GEO) database
(http://www.ncbi.nlm.nih.gov/gds) under the accession number GSE47851.
SUPPLEMENTAL INFORMATION
Supplemental Information include four figures and one table and can be found
with this article online at http://dx.doi.org/10.1016/j.immuni.2014.01.012.
ACKNOWLEDGMENTS
We thank Ronald Germain, Dragana Jankovic, William Paul, and John O’Shea
for their critical reading of our manuscript; Julie Edwards for her excellent
assistance in cell sorting; the NHLBI DNA Sequencing and Computational
Biology Core for sequencing the RNA-seq libraries; and Naofumi Takemoto,
Hidehiro Yamane, George Punkosdy, Michelle Crank, Amina Metidji, Liying
Guo, and Giuseppe Sciume for their helpful discussions. The work was sup-
ported by the NIH NIAID Division of Intramural Research (DIR) and NHLBI DIR.
Received: July 16, 2013
Accepted: January 28, 2014
Published: March 13, 2014
REFERENCES
Bernink, J.H., Peters, C.P., Munneke, M., te Velde, A.A., Meijer, S.L., Weijer,
K., Hreggvidsdottir, H.S., Heinsbroek, S.E., Legrand, N., Buskens, C.J.,
et al. (2013). Human type 1 innate lymphoid cells accumulate in inflamed
mucosal tissues. Nat. Immunol. 14, 221–229.
Buonocore, S., Ahern, P.P., Uhlig, H.H., Ivanov, I.I., Littman, D.R., Maloy, K.J.,
and Powrie, F. (2010). Innate lymphoid cells drive interleukin-23-dependent
innate intestinal pathology. Nature 464, 1371–1375.
Chang, Y.J., Kim, H.Y., Albacker, L.A., Baumgarth, N., McKenzie, A.N., Smith,
D.E., Dekruyff, R.H., and Umetsu, D.T. (2011). Innate lymphoid cells mediate
influenza-induced airway hyper-reactivity independently of adaptive immunity.
Nat. Immunol. 12, 631–638.
Cherrier, M., Sawa, S., and Eberl, G. (2012). Notch, Id2, and RORgt sequen-
tially orchestrate the fetal development of lymphoid tissue inducer cells.
J. Exp. Med. 209, 729–740.
Doherty, T.A., Khorram, N., Lund, S., Mehta, A.K., Croft, M., and Broide, D.H.
(2013). Lung type 2 innate lymphoid cells express cysteinyl leukotriene recep-
tor 1, which regulates TH2 cytokine production. J. Allergy Clin. Immunol. 132,
205–213.
Eberl, G., Marmon, S., Sunshine, M.J., Rennert, P.D., Choi, Y., and Littman,
D.R. (2004). An essential function for the nuclear receptor RORgamma(t) in
the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5, 64–73.
Fallon, P.G., Ballantyne, S.J., Mangan, N.E., Barlow, J.L., Dasvarma, A.,
Hewett, D.R., McIlgorm, A., Jolin, H.E., and McKenzie, A.N. (2006).
Identification of an interleukin (IL)-25-dependent cell population that provides
IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 203,
1105–1116.
Fuchs, A., Vermi, W., Lee, J.S., Lonardi, S., Gilfillan, S., Newberry, R.D., Cella,
M., and Colonna, M. (2013). Intraepithelial type 1 innate lymphoid cells are a
unique subset of IL-12- and IL-15-responsive IFN-g-producing cells.
Immunity 38, 769–781.
Furusawa, J., Moro, K., Motomura, Y., Okamoto, K., Zhu, J., Takayanagi, H.,
Kubo,M., and Koyasu, S. (2013). Critical role of p38 andGATA3 in natural help-
er cell function. J. Immunol. 191, 1818–1826.
Gascoyne, D.M., Long, E., Veiga-Fernandes, H., de Boer, J., Williams, O.,
Seddon, B., Coles, M., Kioussis, D., and Brady, H.J. (2009). The basic leucine
zipper transcription factor E4BP4 is essential for natural killer cell develop-
ment. Nat. Immunol. 10, 1118–1124.
Immunity
GATA3 Regulates IL-7Ra-Expressing ILC DevelopmentHalim, T.Y., Krauss, R.H., Sun, A.C., and Takei, F. (2012a). Lung natural helper
cells are a critical source of Th2 cell-type cytokines in protease allergen-
induced airway inflammation. Immunity 36, 451–463.
Halim, T.Y., MacLaren, A., Romanish, M.T., Gold, M.J., McNagny, K.M., and
Takei, F. (2012b). Retinoic-acid-receptor-related orphan nuclear receptor
alpha is required for natural helper cell development and allergic inflammation.
Immunity 37, 463–474.
Ho, I.C., Tai, T.S., and Pai, S.Y. (2009). GATA3 and the T-cell lineage: essential
functions before and after T-helper-2-cell differentiation. Nat. Rev. Immunol. 9,
125–135.
Hoyler, T., Klose, C.S., Souabni, A., Turqueti-Neves, A., Pfeifer, D., Rawlins,
E.L., Voehringer, D., Busslinger, M., and Diefenbach, A. (2012). The transcrip-
tion factor GATA-3 controls cell fate and maintenance of type 2 innate
lymphoid cells. Immunity 37, 634–648.
Kamizono, S., Duncan, G.S., Seidel, M.G., Morimoto, A., Hamada, K.,
Grosveld, G., Akashi, K., Lind, E.F., Haight, J.P., Ohashi, P.S., et al. (2009).
Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo.
J. Exp. Med. 206, 2977–2986.
Kanno, Y., Vahedi, G., Hirahara, K., Singleton, K., and O’Shea, J.J. (2012).
Transcriptional and epigenetic control of T helper cell specification: molecular
mechanisms underlying commitment and plasticity. Annu. Rev. Immunol. 30,
707–731.
Klein Wolterink, R.G., Serafini, N., van Nimwegen, M., Vosshenrich, C.A., de
Bruijn, M.J., Fonseca Pereira, D., Veiga Fernandes, H., Hendriks, R.W., and
Di Santo, J.P. (2013). Essential, dose-dependent role for the transcription fac-
tor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells.
Proc. Natl. Acad. Sci. USA 110, 10240–10245.
Klose, C.S., Kiss, E.A., Schwierzeck, V., Ebert, K., Hoyler, T., d’Hargues, Y.,
Go¨ppert, N., Croxford, A.L., Waisman, A., Tanriver, Y., and Diefenbach, A.
(2013). A T-bet gradient controls the fate and function of CCR6-RORgt+ innate
lymphoid cells. Nature 494, 261–265.
Lee, J.S., Cella, M., McDonald, K.G., Garlanda, C., Kennedy, G.D., Nukaya,
M., Mantovani, A., Kopan, R., Bradfield, C.A., Newberry, R.D., and Colonna,
M. (2012). AHR drives the development of gut ILC22 cells and postnatal
lymphoid tissues via pathways dependent on and independent of Notch.
Nat. Immunol. 13, 144–151.
Liang, H.E., Reinhardt, R.L., Bando, J.K., Sullivan, B.M., Ho, I.C., and
Locksley, R.M. (2012). Divergent expression patterns of IL-4 and IL-13 define
unique functions in allergic immunity. Nat. Immunol. 13, 58–66.
Mjo¨sberg, J.M., Trifari, S., Crellin, N.K., Peters, C.P., van Drunen, C.M., Piet,
B., Fokkens, W.J., Cupedo, T., and Spits, H. (2011). Human IL-25- and
IL-33-responsive type 2 innate lymphoid cells are defined by expression of
CRTH2 and CD161. Nat. Immunol. 12, 1055–1062.
Mjo¨sberg, J., Bernink, J., Golebski, K., Karrich, J.J., Peters, C.P., Blom, B., te
Velde, A.A., Fokkens, W.J., van Drunen, C.M., and Spits, H. (2012). The tran-
scription factor GATA3 is essential for the function of human type 2 innate
lymphoid cells. Immunity 37, 649–659.
Monticelli, L.A., Sonnenberg, G.F., Abt, M.C., Alenghat, T., Ziegler, C.G.,
Doering, T.A., Angelosanto, J.M., Laidlaw, B.J., Yang, C.Y., Sathaliyawala,
T., et al. (2011). Innate lymphoid cells promote lung-tissue homeostasis after
infection with influenza virus. Nat. Immunol. 12, 1045–1054.
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H.,
Furusawa, J., Ohtani, M., Fujii, H., and Koyasu, S. (2010). Innate production
of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid
cells. Nature 463, 540–544.
Mortazavi, A., Williams, B.A., McCue, K., Schaeffer, L., and Wold, B. (2008).
Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat.
Methods 5, 621–628.
Neill, D.R., Wong, S.H., Bellosi, A., Flynn, R.J., Daly, M., Langford, T.K., Bucks,
C., Kane, C.M., Fallon, P.G., Pannell, R., et al. (2010). Nuocytes represent a
new innate effector leukocyte that mediates type-2 immunity. Nature 464,
1367–1370.Pai, S.Y., Truitt, M.L., Ting, C.N., Leiden, J.M., Glimcher, L.H., and Ho, I.C.
(2003). Critical roles for transcription factor GATA-3 in thymocyte develop-
ment. Immunity 19, 863–875.
Possot, C., Schmutz, S., Chea, S., Boucontet, L., Louise, A., Cumano, A., and
Golub, R. (2011). Notch signaling is necessary for adult, but not fetal, develop-
ment of RORgt(+) innate lymphoid cells. Nat. Immunol. 12, 949–958.
Powell, N., Walker, A.W., Stolarczyk, E., Canavan, J.B., Go¨kmen, M.R., Marks,
E., Jackson, I., Hashim, A., Curtis, M.A., Jenner, R.G., et al. (2012). The tran-
scription factor T-bet regulates intestinal inflammation mediated by inter-
leukin-7 receptor+ innate lymphoid cells. Immunity 37, 674–684.
Price, A.E., Liang, H.E., Sullivan, B.M., Reinhardt, R.L., Eisley, C.J., Erle, D.J.,
and Locksley, R.M. (2010). Systemically dispersed innate IL-13-expressing
cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 107, 11489–11494.
Robinson, M.D., McCarthy, D.J., and Smyth, G.K. (2010). edgeR: a
Bioconductor package for differential expression analysis of digital gene
expression data. Bioinformatics 26, 139–140.
Saenz, S.A., Siracusa, M.C., Perrigoue, J.G., Spencer, S.P., Urban, J.F., Jr.,
Tocker, J.E., Budelsky, A.L., Kleinschek, M.A., Kastelein, R.A., Kambayashi,
T., et al. (2010). IL25 elicits a multipotent progenitor cell population that
promotes T(H)2 cytokine responses. Nature 464, 1362–1366.
Saenz, S.A., Siracusa, M.C., Monticelli, L.A., Ziegler, C.G., Kim, B.S., Brestoff,
J.R., Peterson, L.W., Wherry, E.J., Goldrath, A.W., Bhandoola, A., and Artis, D.
(2013). IL-25 simultaneously elicits distinct populations of innate lymphoid
cells and multipotent progenitor type 2 (MPPtype2) cells. J. Exp. Med. 210,
1823–1837.
Satoh-Takayama, N., Vosshenrich, C.A., Lesjean-Pottier, S., Sawa, S.,
Lochner, M., Rattis, F., Mention, J.J., Thiam, K., Cerf-Bensussan, N.,
Mandelboim, O., et al. (2008). Microbial flora drives interleukin 22 production
in intestinal NKp46+ cells that provide innate mucosal immune defense.
Immunity 29, 958–970.
Sciume´, G., Hirahara, K., Takahashi, H., Laurence, A., Villarino, A.V., Singleton,
K.L., Spencer, S.P., Wilhelm, C., Poholek, A.C., Vahedi, G., et al. (2012).
Distinct requirements for T-bet in gut innate lymphoid cells. J. Exp. Med.
209, 2331–2338.
Sonnenberg, G.F., and Artis, D. (2012). Innate lymphoid cell interactions with
microbiota: implications for intestinal health and disease. Immunity 37,
601–610.
Spits, H., and Cupedo, T. (2012). Innate lymphoid cells: emerging insights in
development, lineage relationships, and function. Annu. Rev. Immunol. 30,
647–675.
Spits, H., and Di Santo, J.P. (2011). The expanding family of innate lymphoid
cells: regulators and effectors of immunity and tissue remodeling. Nat.
Immunol. 12, 21–27.
Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J.P., Eberl, G.,
Koyasu, S., Locksley, R.M., McKenzie, A.N., Mebius, R.E., et al. (2013).
Innate lymphoid cells—a proposal for uniform nomenclature. Nat. Rev.
Immunol. 13, 145–149.
Sun, Z., Unutmaz, D., Zou, Y.R., Sunshine, M.J., Pierani, A., Brenner-
Morton, S., Mebius, R.E., and Littman, D.R. (2000). Requirement for
RORgamma in thymocyte survival and lymphoid organ development.
Science 288, 2369–2373.
Sun, C.M., Hall, J.A., Blank, R.B., Bouladoux, N., Oukka, M., Mora, J.R., and
Belkaid, Y. (2007). Small intestine lamina propria dendritic cells promote de
novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204,
1775–1785.
Ting, C.N., Olson, M.C., Barton, K.P., and Leiden, J.M. (1996). Transcription
factor GATA-3 is required for development of the T-cell lineage. Nature 384,
474–478.
Vonarbourg, C., Mortha, A., Bui, V.L., Hernandez, P.P., Kiss, E.A., Hoyler, T.,
Flach, M., Bengsch, B., Thimme, R., Ho¨lscher, C., et al. (2010). Regulated
expression of nuclear receptor RORgt confers distinct functional fates to NK
cell receptor-expressing RORgt(+) innate lymphocytes. Immunity 33,
736–751.Immunity 40, 378–388, March 20, 2014 ª2014 Elsevier Inc. 387
Immunity
GATA3 Regulates IL-7Ra-Expressing ILC DevelopmentVosshenrich, C.A., Garcı´a-Ojeda, M.E., Samson-Ville´ger, S.I., Pasqualetto, V.,
Enault, L., Richard-Le Goff, O., Corcuff, E., Guy-Grand, D., Rocha, B.,
Cumano, A., et al. (2006). A thymic pathway of mouse natural killer cell devel-
opment characterized by expression of GATA-3 and CD127. Nat. Immunol. 7,
1217–1224.
Walker, J.A., Barlow, J.L., and McKenzie, A.N. (2013). Innate lymphoid cells—
how did we miss them? Nat. Rev. Immunol. 13, 75–87.
Wei, G., Abraham, B.J., Yagi, R., Jothi, R., Cui, K., Sharma, S., Narlikar, L.,
Northrup, D.L., Tang, Q., Paul, W.E., et al. (2011). Genome-wide analyses of
transcription factor GATA3-mediated gene regulation in distinct T cell types.
Immunity 35, 299–311.
Wong, S.H., Walker, J.A., Jolin, H.E., Drynan, L.F., Hams, E., Camelo, A.,
Barlow, J.L., Neill, D.R., Panova, V., Koch, U., et al. (2012). Transcription factor
RORa is critical for nuocyte development. Nat. Immunol. 13, 229–236.
Yagi, R., Junttila, I.S., Wei, G., Urban, J.F., Jr., Zhao, K., Paul, W.E., and Zhu, J.
(2010). The transcription factor GATA3 actively represses RUNX3 protein-
regulated production of interferon-gamma. Immunity 32, 507–517.388 Immunity 40, 378–388, March 20, 2014 ª2014 Elsevier Inc.Yagi, R., Zhu, J., and Paul,W.E. (2011). An updated view on transcription factor
GATA3-mediated regulation of Th1 and Th2 cell differentiation. Int. Immunol.
23, 415–420.
Yang, Q., Monticelli, L.A., Saenz, S.A., Chi, A.W., Sonnenberg, G.F., Tang, J.,
De Obaldia, M.E., Bailis, W., Bryson, J.L., Toscano, K., et al. (2013). T cell
factor 1 is required for group 2 innate lymphoid cell generation. Immunity 38,
694–704.
Yokota, Y., Mansouri, A., Mori, S., Sugawara, S., Adachi, S., Nishikawa, S.,
and Gruss, P. (1999). Development of peripheral lymphoid organs and
natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397,
702–706.
Zhu, J., Min, B., Hu-Li, J., Watson, C.J., Grinberg, A., Wang, Q., Killeen, N.,
Urban, J.F., Jr., Guo, L., and Paul, W.E. (2004). Conditional deletion of
Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat. Immunol.
5, 1157–1165.
Zhu, J., Yamane, H., and Paul, W.E. (2010). Differentiation of effector CD4
T cell populations (*). Annu. Rev. Immunol. 28, 445–489.
